| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_661b3ea63e73acc96731eb73625b1bc2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3515 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2010-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2de44b1e977d8dea2601d7121dd64229
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3be67a01a22602b7638a4b2f12981811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc198c221b039d28abe8505e208e4822
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b00224dd55bf69b4401f2f331dc11518 |
| publicationDate |
2015-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-102421900-B |
| titleOfInvention |
Lipid-formulated compositions and methods for inhibiting Eg5 and VEGF gene expression |
| abstract |
The present invention relates to a composition containing double-stranded ribonucleic acid (dsRNA) in a lipid formulation, and a method for inhibiting the expression of human kinesin family member 11 (Eg5) and vascular endothelial growth factor (VEGF) using the composition, and using the composition The composition is a method of treating pathological processes mediated by Eg5 and VEGF expression, such as cancer. |
| priorityDate |
2009-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |